Overview

Pharmacokinetics of Nalbuphine Injection

Status:
Completed

Trial end date:
2019-01-15

Target enrollment:

Participant gender:

Summary

A study to evaluate pharmacokinetics of nalbuphine hydrochloride (10 mg/mL) after a single intravenous administration in healthy volunteers under fasting conditions

Phase:

Phase 4

Details

Lead Sponsor:

Yung Shin Pharm. Ind. Co., Ltd.

Collaborator:

Taichung Veterans General Hospital

Treatments:

Nalbuphine